Black Diamond Therapeutics, Inc (BDTX) Financials
BDTX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 158.6 million | 41.8 million |
2023-09-30 | 172.4 million | 38.1 million |
2023-06-30 | 119.9 million | 37.7 million |
2023-03-31 | 135.6 million | 37.4 million |
BDTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -14.0 million | 1.5 million |
2023-09-30 | -18.4 million | 2.8 million |
2023-06-30 | -14.4 million | 2.6 million |
2023-03-31 | -20.0 million | 2.7 million |
BDTX Net Income
No data available :(
BDTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 131.4 million | - | 25.3 million |
2023-09-30 | 144.3 million | - | 26.0 million |
2023-06-30 | 89.5 million | - | 26.8 million |
2023-03-31 | 103.4 million | - | 27.5 million |
BDTX Shares Outstanding
BDTX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 15.2 million | 5.6 million | - |
2023-09-30 | 33000 | 16.2 million | 7.9 million | - |
2023-06-30 | 34000 | 13.2 million | 6.9 million | - |
2023-03-31 | - | 14.8 million | 6.8 million | - |
BDTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 86000 |
2023-09-30 | - | 823000 |
2023-06-30 | - | 812000 |
2023-03-31 | - | 812000 |
BDTX
Price: $6.96
52 week price:
Earnings Per Share: -1.88 USD
P/E Ratio: -2.51
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 81500
Market Capitalization: 278.2 million